NCT06227195View on ClinicalTrials.gov

Mechanism of IL-10 Pathway-mediated Regulatory B Cell Dysfunction in Osteoarthritis

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
OsteoarthritisKnee Arthritis
Trial Locations (1)

250014

The First Affiliated Hospital of Shandong First Medical University, Jinan

All Listed Sponsors
lead

Shufeng Li

OTHER

NCT06227195 - Mechanism of IL-10 Pathway-mediated Regulatory B Cell Dysfunction in Osteoarthritis | Biotech Hunter | Biotech Hunter